Cleara Biotech

Cleara Biotech is a pioneering company in the biotechnology sector, focusing on developing innovative therapies that target senescent cells. Senescent cells are cells that have stopped dividing and can contribute to aging and the development of cancer. Cleara Biotech has discovered the mechanism by which these cells escape the body's natural elimination process. By targeting these cells, the company aims to improve health outcomes and extend healthy lifespans. Cleara Biotech primarily serves the healthcare and pharmaceutical industries, offering its groundbreaking solutions to researchers, clinicians, and pharmaceutical companies. The company operates in the global biotechnology market and employs a business model that includes research and development, partnerships, and licensing agreements. Revenue is generated through the development and commercialization of its therapies, as well as through strategic collaborations and licensing deals.

Keywords: senescent cells, aging, cancer, biotechnology, therapies, healthcare, pharmaceutical, research, innovation, lifespan.